Skip to main content
JOHNSON & JOHNSON logo

JOHNSON & JOHNSON — Investor Relations & Filings

Ticker · JNJ ISIN · US4781601046 LEI · 549300G0CFPGEF6X2043 US Manufacturing
Open in API
Filings indexed 3,142 across all filing types
Latest filing 2010-02-05 M&A Activity
Country US United States of America
Listing US JNJ

About JOHNSON & JOHNSON

https://www.jnj.com/

Johnson & Johnson is a healthcare company that operates through two primary segments: Innovative Medicine and MedTech. The Innovative Medicine division is focused on the research, development, and delivery of new treatments for complex diseases in areas such as oncology, immunology, neuroscience, and cardiopulmonary conditions. The MedTech segment develops and provides a broad portfolio of medical technologies and solutions. It innovates in fields including surgery, orthopaedics, vision, and interventional solutions, aiming to create smarter, less invasive, and more personalized healthcare treatments. The company's mission is to address significant health challenges through science-based innovation at the intersection of biology and technology.

Recent filings

Filing Released Lang Actions
ACCLARENT ACQUISITION 8-K
M&A Activity Classification · 100% confidence The document is a Form 8-K filed with the SEC, which is a current report used to announce major events. The text specifically describes the completion of an acquisition by Ethicon, Inc., a subsidiary of Johnson & Johnson, of Acclarent, Inc. It includes details about the transaction and its expected financial impact. The document is not a full annual or quarterly report, nor is it a press release or presentation. It is an announcement of a significant corporate event related to merger and acquisition activity. Therefore, the appropriate classification is 'M&A Activity' (TAR). The document length is 2412 characters, which is consistent with a typical 8-K filing announcing an acquisition event.
2010-02-05 English
AMD TO SCHED 13G FOR OPKO HEALTH BY JOHNSON & JOHNSON
Major Shareholding Notification
2010-02-02 English
Major Shareholding Notification 2010
Major Shareholding Notification
2010-01-29 English
AUTO-GENERATED PAPER DOCUMENT
Regulatory Filings
2010-01-26 English
Earnings Release 2010
Earnings Release Classification · 95% confidence The document is a Form 8-K filed with the SEC, which is a current report used to announce major events. The text specifically mentions Item 2.02 "Results of Operations and Financial Condition" and includes a press release announcing sales and earnings for the fourth quarter ended January 3, 2010. It also references unaudited supplementary sales data and condensed consolidated statement of earnings for the quarter. The document is short (2374 characters) and primarily serves as an announcement of financial results rather than a full detailed earnings report or annual report. Form 8-K filings with earnings announcements are typically classified as Earnings Release (ER). Therefore, the appropriate classification is Earnings Release (ER).
2010-01-26 English
PRIMARY DOCUMENT
Director's Dealing
2010-01-05 English

Browse filings by year

27 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.